Brief: Bone Biologics CEO Issues Letter To Stockholders Highlighting Company Update And Outlook
04/09/2025 12:01
Bone Biologics Corp BBLG.O: BONE BIOLOGICS CEO ISSUES LETTER TO STOCKHOLDERS HIGHLIGHTING COMPANY UPDATE AND OUTLOOK BONE BIOLOGICS CORP: EXPECT CURRENT CASH POSITION TO FUND PLANNED OPERATIONS INTO Q2 OF 2026 Source text: ID:nBw4VDNbya Further company coverage: BBLG.O
Recent news on Bone Biologics
See all newsBone Biologics Corp expected to post a loss of 39 cents a share - Earnings Preview
Brief: Bone Biologics Extends Rhnell-1 Shelf Life To 24 Months
Brief: Bone Biologics CEO Issues Letter To Stockholders Highlighting Company Update And Outlook
Bone Biologics Corp expected to post a loss of 53 cents a share - Earnings Preview
Bone Biologics Corp expected to post a loss of 58 cents a share - Earnings Preview